Grant for the support the development of MAP for self-administration of contraceptives
ltslohmann.com · 679 words · saved by 1 readers
Grant for the support the development of MAP for self-administration of contraceptives for women in low- and middle-income countries (LMICs)
Skip to content December 19, 2023 Andernach – LTS, a leading pharmaceutical technology company, announced today that it has received a grant from the Bill & Melinda Gates Foundation. The purpose of the grant is to support the development of microneedle array patches (MAP) for self-administration of contraceptives for women in low- and middle-income countries (LMICs). The grant will fund $4.3 million over a duration of 25 months. Poor access to contraceptives presents a significant burden for women living in LMICs. According to a 2022 study, one in 14 women worldwide who want to use…
saved by
related reading
- Axmed - Accelerating Access to Medicines for Allaxmed.com
- The Global Fund's Procurement Platformwambo.org
- Gap Mapgap-map.org
- New HIV Frontier: The Fight To Access Long-Acting Prevention Drugs - Health Policy Watchhealthpolicy-watch.news
- Vaginal Drug Delivery Had A Funding Problem—Merck Changed Thatforbes.com
- Thousands more B.C. women chose top-tier birth control after patient costs eliminatednews.ubc.ca
- Home - Concept Foundationconceptfoundation.org
- Why Women Hate the Pill | The Walrusthewalrus.ca
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- ActiPatch: Can It be a Tool to Empower Chronic Pain Patients?ncbi.nlm.nih.gov
- Flo prosocial campaign: Flo premium subscription freeflo.health
- Effective Altruism focused on bednets while a malaria vaccine was stuck for 23 years. The case for Abundance.substack.com